SeqLL Inc. Logo

SeqLL Inc.

SQL

(0.0)
Stock Price

6,60 USD

-65.96% ROA

-142.92% ROE

-20.81x PER

Market Cap.

2.511.934,00 USD

103.82% DER

0% Yield

-6023% NPM

SeqLL Inc. Stock Analysis

SeqLL Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

SeqLL Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE indicates a negative return (-103.48%) on shareholders' equity, suggesting poor financial performance.

2 ROA

The stock's ROA (-65.96%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

3 PBV

The stock's elevated P/BV ratio (32.21x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

4 DER

The company has a high debt to equity ratio (104%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

SeqLL Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

SeqLL Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

SeqLL Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

SeqLL Inc. Revenue
Year Revenue Growth
2017 1.338.752
2018 779.068 -71.84%
2019 160.480 -385.46%
2020 50.588 -217.23%
2021 48.021 -5.35%
2022 1.177 -3979.95%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

SeqLL Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2017 974.531
2018 1.039.260 6.23%
2019 1.245.168 16.54%
2020 330.979 -276.21%
2021 530.076 37.56%
2022 1.568.266 66.2%
2023 1.645.328 4.68%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

SeqLL Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2017 806.897
2018 1.466.814 44.99%
2019 1.359.497 -7.89%
2020 777.435 -74.87%
2021 2.170.857 64.19%
2022 2.506.851 13.4%
2023 3.510.448 28.59%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

SeqLL Inc. EBITDA
Year EBITDA Growth
2017 -1.454.558
2018 -1.898.770 23.39%
2019 -2.169.767 12.49%
2020 -649.397 -234.12%
2021 -2.467.953 73.69%
2022 -3.864.332 36.14%
2023 -4.990.452 22.57%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

SeqLL Inc. Gross Profit
Year Gross Profit Growth
2017 254.234
2018 104.787 -142.62%
2019 -59.283 276.76%
2020 -120.215 50.69%
2021 -9.669 -1143.3%
2022 487 2085.42%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

SeqLL Inc. Net Profit
Year Net Profit Growth
2017 -1.706.934
2018 -2.888.017 40.9%
2019 -2.655.799 -8.74%
2020 -1.524.116 -74.25%
2021 -3.906.078 60.98%
2022 -4.192.518 6.83%
2023 -5.070.672 17.32%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

SeqLL Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2017 -14
2018 -24 39.13%
2019 -22 -9.52%
2020 -13 -75%
2021 -22 42.86%
2022 -14 -50%
2023 -13 -7.69%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

SeqLL Inc. Free Cashflow
Year Free Cashflow Growth
2017 -1.136.678
2018 -1.781.864 36.21%
2019 -1.585.331 -12.4%
2020 -757.911 -109.17%
2021 -2.004.347 62.19%
2022 -3.702.588 45.87%
2023 -1.049.772 -252.7%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

SeqLL Inc. Operating Cashflow
Year Operating Cashflow Growth
2017 -1.125.597
2018 -1.781.864 36.83%
2019 -1.585.331 -12.4%
2020 -757.911 -109.17%
2021 -1.989.877 61.91%
2022 -3.662.568 45.67%
2023 -1.049.770 -248.89%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

SeqLL Inc. Capital Expenditure
Year Capital Expenditure Growth
2017 11.081
2018 0 0%
2019 0 0%
2020 0 0%
2021 14.470 100%
2022 40.020 63.84%
2023 2 -2000900%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

SeqLL Inc. Equity
Year Equity Growth
2017 -1.754.383
2018 -386.413 -354.02%
2019 -2.829.023 86.34%
2020 -3.854.166 26.6%
2021 8.182.368 147.1%
2022 4.366.886 -87.37%
2023 1.752.747 -149.15%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

SeqLL Inc. Assets
Year Assets Growth
2017 1.079.515
2018 1.180.277 8.54%
2019 888.405 -32.85%
2020 694.043 -28%
2021 10.740.137 93.54%
2022 8.414.241 -27.64%
2023 5.507.733 -52.77%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

SeqLL Inc. Liabilities
Year Liabilities Growth
2017 2.833.898
2018 1.566.690 -80.88%
2019 3.717.428 57.86%
2020 4.548.209 18.27%
2021 2.557.769 -77.82%
2022 4.047.355 36.8%
2023 3.754.986 -7.79%

SeqLL Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.01
Net Income per Share
-0.32
Price to Earning Ratio
-20.81x
Price To Sales Ratio
31.93x
POCF Ratio
-19.99
PFCF Ratio
-0.54
Price to Book Ratio
31.44
EV to Sales
9.5
EV Over EBITDA
-0.14
EV to Operating CashFlow
-0.16
EV to FreeCashFlow
-0.16
Earnings Yield
-0.05
FreeCashFlow Yield
-1.85
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
1.22
Graham NetNet
0.07

Income Statement Metrics

Net Income per Share
-0.32
Income Quality
0.87
ROE
-1.03
Return On Assets
-0.86
Return On Capital Employed
-1.28
Net Income per EBT
0.84
EBT Per Ebit
0.98
Ebit per Revenue
-72.93
Effective Tax Rate
0.15

Margins

Sales, General, & Administrative to Revenue
39.92
Research & Developement to Revenue
28.3
Stock Based Compensation to Revenue
4.11
Gross Profit Margin
0.99
Operating Profit Margin
-72.93
Pretax Profit Margin
-71.48
Net Profit Margin
-60.23

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.33
Free CashFlow per Share
-0.34
Capex to Operating CashFlow
0.02
Capex to Revenue
-0.93
Capex to Depreciation
-0.58
Return on Invested Capital
-0.59
Return on Tangible Assets
-0.66
Days Sales Outstanding
12.64
Days Payables Outstanding
201988.88
Days of Inventory on Hand
0
Receivables Turnover
28.89
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-0.01

Balance Sheet

Cash per Share
0,34
Book Value per Share
0,21
Tangible Book Value per Share
0.21
Shareholders Equity per Share
0.21
Interest Debt per Share
0.22
Debt to Equity
1.04
Debt to Assets
0.45
Net Debt to EBITDA
0.34
Current Ratio
5.04
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
1.04
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
1.2

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

SeqLL Inc. Dividends
Year Dividends Growth

SeqLL Inc. Profile

About SeqLL Inc.

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.

CEO
Mr. Daniel Robert Jones
Employee
7
Address
3 Federal Street
Billerica, 01821

SeqLL Inc. Executives & BODs

SeqLL Inc. Executives & BODs
# Name Age
1 Mr. John W. Kennedy
Chief Financial Officer & Sec.
70
2 Mr. Daniel Robert Jones
Co-Founder, President, Chief Executive Officer & Chairman
70
3 Ms. Frances P. Scally
Chief Financial Officer & Secretary
70
4 Mr. Brian Paras
Chief Business Officer
70
5 Mr. Erik Volke
Director of Operations
70

SeqLL Inc. Competitors